Page last updated: 2024-08-22

vidarabine and 2'-deoxyadenosine triphosphate

vidarabine has been researched along with 2'-deoxyadenosine triphosphate in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19906 (85.71)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kufe, D; Matsukage, A; Ohno, T; Ohno, Y; Spriggs, D1
Heike, T; Katamura, K; Kubota, M; Mikawa, H; Shinomiya, K1
Benjamin, RS; Freireich, EJ; Keating, MJ; Plunkett, W1
Coleman, MS; Siaw, MF1
Eyring, H; Miles, DL; Miles, DW1
Hallam, LJ; Jack, I; Van Der Weyden, MB; Young, GJ1
Hori, H; Kawai, Y; Ueda, T; Yoshio, N1

Other Studies

7 other study(ies) available for vidarabine and 2'-deoxyadenosine triphosphate

ArticleYear
Sequence-specific inhibition of DNA strand elongation by incorporation of 9-beta-D-arabinofuranosyladenine.
    Cancer research, 1989, Apr-15, Volume: 49, Issue:8

    Topics: Base Sequence; Deoxyadenine Nucleotides; DNA; DNA Polymerase I; Vidarabine; Vidarabine Phosphate

1989
Inhibitor of 2', 5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
    Advances in experimental medicine and biology, 1986, Volume: 195 Pt B

    Topics: 2',5'-Oligoadenylate Synthetase; Adenosine; Cell Line; Coformycin; Deoxyadenine Nucleotides; Deoxyadenosines; Enzyme Induction; Homocysteine; Humans; Interferon Type I; Pentostatin; Ribonucleosides; T-Lymphocytes; Vidarabine

1986
Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine.
    Cancer research, 1982, Volume: 42, Issue:5

    Topics: Adult; Arabinonucleotides; Cell Line; Chromatography, High Pressure Liquid; Coformycin; Deoxyadenine Nucleotides; DNA; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Male; Pentostatin; Ribonucleosides; Vidarabine; Vidarabine Phosphate

1982
In vitro metabolism of deoxycoformycin in human T lymphoblastoid cells. Phosphorylation of deoxycoformycin and incorporation into cellular DNA.
    The Journal of biological chemistry, 1984, Aug-10, Volume: 259, Issue:15

    Topics: Adenosine Deaminase Inhibitors; Adenosine Kinase; Chromatography, High Pressure Liquid; Coformycin; Deoxyadenine Nucleotides; Deoxyadenosines; Deoxycytidine Kinase; DNA; Humans; Nucleoside Deaminases; Pentostatin; Phosphorylation; Ribonucleosides; RNA; T-Lymphocytes; Vidarabine

1984
Biochemical and biophysical approaches to improving the anticancer effectiveness of Ara-adenine.
    Medical hypotheses, 1982, Volume: 9, Issue:5

    Topics: Adenosine Deaminase Inhibitors; Animals; Antineoplastic Agents; Cytarabine; Deoxyadenine Nucleotides; Deoxycytidine Kinase; Homocysteine; Humans; Isoenzymes; Neoplasms; Nucleotides, Cyclic; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Conformation; Vidarabine

1982
S-adenosylhomocysteine hydrolase inactivation and purine toxicity in cultured human T- and B-lymphoblasts.
    The Journal of laboratory and clinical medicine, 1984, Volume: 104, Issue:1

    Topics: Adenosine Kinase; Adenosylhomocysteinase; B-Lymphocytes; Cell Line; Deoxyadenine Nucleotides; Deoxyadenosines; Deoxycytidine Kinase; Humans; Hydrolases; Phosphotransferases; Purine Nucleosides; T-Lymphocytes; Vidarabine

1984
Resistance to 9-beta-D-arabinofuranosyl-2-fluoroadenine due to reduced incorporation into DNA from competition by excess deoxyadenosine triphosphate: implications for different sensitivities to nucleoside analogues.
    International journal of hematology, 2005, Volume: 81, Issue:5

    Topics: Animals; Binding, Competitive; Biotransformation; Cell Line, Tumor; Cell Proliferation; Cytarabine; Deoxyadenine Nucleotides; Deoxycytosine Nucleotides; DNA; Drug Interactions; Drug Resistance, Neoplasm; Hydroxyurea; Mice; Nucleosides; Vidarabine

2005